|
|
|
42
|
3633AG
|
METOCLOPRAMIDE 5MG/ML IV/IM INJ (MO
|
METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
10X2ML
|
B
|
6.47
|
0.65
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5632
|
GI PROKINETIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
GI PROKINETIC AGENTS
|
|
|
|
|
41
|
3633AV
|
METOCLOPRAMIDE 5MG/ML IV/IM INJ (FSB) (B)
|
METOCLOPRAMIDE
|
METOCLOPRAMIDE
|
10X2ML
|
B
|
4.32
|
0.4322
|
AMP
|
0
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
GI PROKINETIC AGENTS
|
|
|
|
|
40
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR/COL) BUDESONIDE
|
BUDESONIDE
|
RYNASE AQ
|
240 DOSES
|
A
|
15.98
|
15.98
|
NASAL SPRAY
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR) BUDESONID
|
BUDESONIDE
|
RYNASE AQ
|
240 DOSES
|
A
|
16.26
|
16.2556
|
BOTT
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR) BUDESONID
|
BUDESONIDE
|
RYNASE AQ
|
240 DOSES
|
A
|
16.26
|
16.26
|
BOTT
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
AVENTA BARBADOS
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK/COL) FLUTICASONE
|
FLUTICASONE
|
AVAMYS
|
120 DOSES
|
C
|
25.14
|
25.14
|
NASAL SPRAY
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK) FLUTICASON (C)
|
FLUTICASONE
|
AVAMYS
|
120 DOSES
|
C
|
26.67
|
26.6668
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK) FLUTICASONE
|
FLUTICASONE
|
AVAMYS
|
120 DOSES
|
C
|
29.33
|
29.33
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653BK
|
RYNASE AQ 32MCG NASAL SP (CAR/COL) BUDESONIDE
|
BUDESONIDE
|
RYNASE AQ
|
120 DOSES
|
C
|
8.15
|
8.15
|
NASAL SPRAY
|
0
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653BK
|
RYNASE AQ 32MCG NASAL SP (CAR) BUDESONID (C)
|
BUDESONIDE
|
RYNASE AQ
|
120 DOSES
|
C
|
8.43
|
8.4268
|
BOTT
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR/COL) MOMETASO
|
MOMETASONE
|
NASASONE MF
|
140 DOSES
|
C
|
9.65
|
9.65
|
NASAL SPRAY
|
0
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR) MOMETAS
|
MOMETASONE
|
NASASONE MF
|
140 DOSES
|
A
|
9.24
|
9.2423
|
BOTT
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR) MOMETAS
|
MOMETASONE
|
NASASONE MF
|
140 DOSES
|
C
|
9.24
|
9.24
|
BOTT
|
1
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
AVENTA BARBADOS
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653CD
|
BUDESONIDE 64MCG NASAL SP (CIR)
|
BUDESONIDE
|
BUDESONIDE
|
200 DOSES
|
A
|
14.43
|
14.43
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653CE
|
FLUTICASONE 27.5MCG NASAL SP (CIR/AHI)
|
FLUTICASONE
|
FLUTICASONE
|
200 DOSES
|
A
|
14.68
|
14.68
|
NASAL SPRAY
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2022-09-30
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
41
|
3653CE
|
FLUTICASONE 27.5MCG NASAL SP (CIR)
|
FLUTICASONE
|
FLUTICASONE
|
200 DOSES
|
A
|
14.14
|
14.1353
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653CF
|
FLUTICASONE 50MCG NASAL SP (CIR/AHI)
|
FLUTICASONE
|
FLUTICASONE
|
200 DOSES
|
A
|
14.08
|
14.08
|
NASAL SPRAY
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653CF
|
FLUTICASONE 50MCG NASAL SP (CIR)
|
FLUTICASONE
|
FLUTICASONE
|
200 DOSES
|
A
|
15.28
|
15.277
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
3653CK
|
MOMETASONE 50MCG NASAL SP (BCH/COL)
|
MOMETASONE
|
MOMETASONE
|
140 DOSES
|
A
|
9.08
|
9.08
|
NASAL SPRAY
|
1
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat A
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2021-07-29
|
|
|
|
40
|
3653CS
|
FLUTICASONE 27.5MCG NASAL SP (ARP/AHI)
|
FLUTICASONE
|
FLUTICASONE
|
120 DOSES
|
A
|
12.99
|
12.99
|
NASAL SPRAY
|
1
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|